Our data indicate that two LABAs, formoterol and salmeterol, both of which are frequently used in COPD therapy, can reverse the corticosteroid-insensitivity of IL-8 in COPD-relevant pre-clinical HASMC culture models. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.